Mission:
Our mission is to restore hope among vulnerable children and communities that have been affected by poverty, abuse, violence, disease and other natural calamities.
We strive to reduce poverty and its effects among disadvantaged children and communities in Uganda by focusing on smaller groups of children, youths and women as our change agents.
Objectives:
Our MAIN objective is to provide a holistic transformation of young people and disadvantaged communities by offering training, empowerment and exposure to life-changing innovations.
Our SPECIFIC Objectives are:
* To mobilize resources and establish educational opportunities for vulnerable children without any form of discrimination based on religion, tribe, gender, sex, race e.t.c
* To ensure that children are safe, healthy and protected at home, in schools and communities.
* To facilitate the rehabilitation of traumatized children through sports, music, dance, and drama.
* To support community-led initiatives with focus on using sustainable technologies to enhance development.
Our core values:
Five core values that steer our day-to-day standards of operations are:
1. Accountability and Transparency in all our dealings
2. Creating Value for our stakeholders
3. Pursuit of Excellence and continuous Improvement
4. Commitment to personal Integrity
5. Creating a culture of Team Work
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close